A23V 2250/1642
Zinc
A23V2250/1642 (Zinc) appears on 21 US grants and 34 published applications in this corpus.
Search patents in A23V- Granted patents
- 21
- Published applications
- 34
- Assignees
- 15
- Inventors
- 48
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 0 |
| 2018 | 2 | 3 |
| 2019 | 0 | 13 |
| 2020 | 4 | 3 |
| 2021 | 2 | 0 |
| 2022 | 7 | 3 |
| 2023 | 0 | 3 |
| 2024 | 3 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Nutritional compositions and infant formula for promoting de novo myealination21 Jul 2026US 12,685,331 B2Societe des Produits Nestle S. A.
- Nutritional composition and infant formula for promoting de novo myelination2 Dec 2025US 12,484,608 B2Societe des Produits Nestle S. A.
- Nutritional supplements22 Oct 2024US 12,121,050 B2Laminaria Group AB
- Nutritional composition and infant formula for promoting de novo myelination21 May 2024US 11,986,003 B2Societe des Produits Nestle S. A.
- Nutritional composition and infant formula for promoting myelination of the brain19 Mar 2024US 11,930,836 B2Societe des Produits Nestle S. A.
- Compositions and their use11 Sep 2025US 2025/0280863 A1Societe des Produits Nestle S. A.
- Nutritional supplements1 May 2025US 2025/0134150 A1Laminaria Group AB
- Nutritional composition and infant formula for promoting de novo myelination24 Oct 2024US 2024/0349771 A1Societe des Produits Nestle S. A.
- Nutritional supplements20 Jul 2023US 2023/0225384 A1Laminaria Group AB
- Nutritional compositions and infant formula for promoting de novo myealination19 Jan 2023US 2023/0015563 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Accelerating muscle recovery after immobilization-induced muscle atrophy16US 9,867,391 B2Nestec S. A. · 2018
- Nutritional formulations using human milk oligosaccharides for modulating inflammation2US 10,624,916 B2Abbott Laboratories · 2020
- Ultra low dose nutraceutical compositions for enhancing sleep quality and treating sleep disorders2US 9,549,982 B2Foundational Biosystems, LLC · 2017
- Gel formulation for the prevention and treatment of gastrointestinal distress in horses and other species1US 10,758,562 B2KAECO Group, Inc. · 2020